{"slug":"consensus","tag":"consensus","variants":["consensus"],"description":"No description yet","count":1,"kinds":{"paper":1},"related":[{"slug":"clinical-utility","tag":"clinical-utility","shared":1},{"slug":"ctc","tag":"ctc","shared":1}],"records":[{"id":"paper-nicolo-ctc-consensus-ejc-2025","kind":"paper","name":"International expert consensus on the clinical integration of circulating tumor cells in solid tumors","route":"/key-papers/paper-nicolo-ctc-consensus-ejc-2025/","tldr":"A 37-expert consensus supported selected circulating tumour cell uses in metastatic breast and prostate cancer but said most other uses remain investigational. It identified CellSearch as the only platform with high-level clinical-use evidence and did not evaluate or endorse RGCC tests."}]}